Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H24N2O2 |
| Molecular Weight | 324.4168 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C
InChI
InChIKey=LOUPRKONTZGTKE-FEBSWUBLSA-N
InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20-/m0/s1
| Molecular Formula | C20H24N2O2 |
| Molecular Weight | 324.4168 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1510452Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/10191268 |
https://www.ncbi.nlm.nih.gov/pubmed/7925942 | https://www.ncbi.nlm.nih.gov/pubmed/10530923
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1510452
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/10191268 |
https://www.ncbi.nlm.nih.gov/pubmed/7925942 | https://www.ncbi.nlm.nih.gov/pubmed/10530923
Epiquinine is a stereoisomer of quinine, antimalarial alkoloid from the bark of a cinchona tree. Quinine was over 100 times more active than epiquinine against chloroquine-sensitive Plasmodium falciparum and over 10 times more active against chloroquine-resistant P. falciparum. Intra-erythrocytically active anti-malarial quinine acts by binding to haematin, blocking beta-haematin formation (while the anti-malarially inactive epiquinine had no effect on the reaction, however as quinine epiquinine was reported to bind ferriprotoporphyrin IX) and leaving toxic haematin in the parasite food vacuoles. Distinguishing features of the weakly active epiquinine include a higher dipole moment, a different direction of the electric field, a greater intrinsic nucleophilicity, lower acidity of the hydroxyl proton, a lesser electron affinity of the lowest unoccupied molecular orbitals, and a higher proton affinity than the active cinchona alkaloids. Epiquinine has little inhibitory effect toward peroxidative destruction of haem.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL613897 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9336973 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial cinchona alkaloids. | 2012-10 |
|
| Iron(III) protoporphyrin IX complexes of the antimalarial Cinchona alkaloids quinine and quinidine. | 2012-04-20 |
|
| The crystal structure of halofantrine-ferriprotoporphyrin IX and the mechanism of action of arylmethanol antimalarials. | 2008-08 |
|
| Stereoelectronic features of the cinchona alkaloids determine their differential antimalarial activity. | 1999-09 |
|
| Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. | 1999-04-15 |
|
| Thermodynamic factors controlling the interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX. | 1997-11-01 |
|
| Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). | 1994-09-19 |
|
| Structure of 9-epiquinine hydrochloride dihydrate versus antimalarial activity. | 1992-11-15 |
|
| Stereochemical evaluation of the relative activities of the cinchona alkaloids against Plasmodium falciparum. | 1992-07 |
|
| [Heart and circulatory effects of quinidine stereoisomers]. | 1976-11 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:27:35 GMT 2025
by
admin
on
Mon Mar 31 22:27:35 GMT 2025
|
| Record UNII |
4M9989F55E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m4946
Created by
admin on Mon Mar 31 22:27:35 GMT 2025 , Edited by admin on Mon Mar 31 22:27:35 GMT 2025
|
PRIMARY | Merck Index | ||
|
10448938
Created by
admin on Mon Mar 31 22:27:35 GMT 2025 , Edited by admin on Mon Mar 31 22:27:35 GMT 2025
|
PRIMARY | |||
|
209-341-1
Created by
admin on Mon Mar 31 22:27:35 GMT 2025 , Edited by admin on Mon Mar 31 22:27:35 GMT 2025
|
PRIMARY | |||
|
DTXSID80972650
Created by
admin on Mon Mar 31 22:27:35 GMT 2025 , Edited by admin on Mon Mar 31 22:27:35 GMT 2025
|
PRIMARY | |||
|
4M9989F55E
Created by
admin on Mon Mar 31 22:27:35 GMT 2025 , Edited by admin on Mon Mar 31 22:27:35 GMT 2025
|
PRIMARY | |||
|
572-60-1
Created by
admin on Mon Mar 31 22:27:35 GMT 2025 , Edited by admin on Mon Mar 31 22:27:35 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |